Exagen (XGN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 10, 2025, at the Carlsbad, California offices.
Meeting materials include the notice, proxy statement, and 2024 annual report.
Shareholders of record as of April 15, 2025, are eligible to vote.
Voting matters and shareholder proposals
Election of two Class III directors for a three-year term expiring at the 2028 annual meeting.
Ratification of BDO USA, P.C. as independent auditor for fiscal year ending December 31, 2025.
Advisory vote on executive compensation as disclosed in the proxy statement.
Advisory vote on the frequency of future say-on-pay votes.
Board of directors and corporate governance
Board recommends voting for all director nominees and all proposals.
Director nominees are John Aballi and Bruce C. Robertson, Ph.D.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Exagen
- 2025 revenue rose 20% to $66.6M, with improved margins and strong AVISE CTD test growth.XGN
Q4 202510 Mar 2026 - Record Q2 revenue, margin gains, and raised outlook signal progress toward profitability.XGN
Q2 20242 Feb 2026 - Record revenue, margin gains, and new test enhancements set up cash flow positivity by 2025.XGN
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Q3 2024 saw higher ASP, narrowed losses, and new biomarkers set up for 2025 profitability.XGN
Q3 202414 Jan 2026 - Turnaround delivers ASP growth, new products, and a path to cash flow positivity in 2024.XGN
TD Cowen 45th Annual Healthcare Conference30 Dec 2025 - Record revenue, margin expansion, and new biomarkers set up for profitable growth in 2025.XGN
Q4 202426 Dec 2025 - Registering 1,150,000 shares for resale linked to a $75M term loan and warrant agreement.XGN
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and executive pay, with board support for all.XGN
Proxy Filing2 Dec 2025 - Record Q1 revenue of $15.5M, higher ASP, and new credit facility support 2025 growth.XGN
Q1 202523 Nov 2025